Table 3 Disease characteristics of 96 patients treated with minimally invasive Ivor Lewis esophagectomy
From: Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy
| Â | All patients N = 96 |
|---|---|
n (percent, %) or median [interquartile range] or mean ± standard deviation | |
Type of cancer | |
 Adenocarcinoma | 75 (78) |
 Squamous cell carcinoma | 21 (22) |
Neoadjuvant chemoradiotherapy | 88 (92) |
Postoperative histopathology | |
 Pathological tumor-node-metastasis staging | |
  Stage 0 | 23 (24) |
  Stage I | 24 (25) |
  Stage II | 23 (24) |
  Stage III | 20 (21) |
  Stage IVA | 6 (6) |
 Number of lymph nodes harvested | 19.0 [15.0–23.0] |
 Pathological complete response | 11 (12) |
 R0 resection margin | 94 (98) |
 Positive resection margin | 2 (2) |
 Lymphovascular invasion | |
  Present | 25 (26) |
  Absent | 48 (50) |
  Unknown | 23 (24) |